VBI Vaccines
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of VBI Vaccines generated cash of -$60,883,000, which is more than the previous year. Cash used in financing activities reached the amount of $22,698,000 last year. Net change in cash is therefore -$38,944,000.
Cash Flow
| 2013 | -6.46M | -2.07M | 34.39K |
|---|---|---|---|
| 2015 | -9.04M | -526K | 21.63M |
| 2016 | -18.51M | 1.5M | 36.48M |
| 2017 | -31.38M | -579K | 67.23M |
| 2018 | -45.53M | -5.99M | 43.61M |
| 2019 | -48.71M | -3.67M | 37.41M |
| 2020 | -47.05M | -26M | 122.39M |
| 2021 | -39.90M | 23.15M | 44.29M |
| 2022 | -73.69M | -4.34M | 19.44M |
| 2023 | -60.88M | -867K | 22.69M |
VBIV Cash Flow Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 62.62M | 121.69M | 93.82M | 44.21M | 59.27M | 67.69M | 32.28M | 12.47M | 393K | 57.05M |
Operating activities | ||||||||||
Net income | -92.83M | -113.30M | -69.75M | -46.23M | -54.81M | -63.6M | -38.99M | -23.20M | -14.75M | -6.65M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.99M | 2.06M | 1.83M | 1.65M | 1.20M | 542K | 730K | 606K | 1.14M | 34.87K |
Stock-based compensation expense | 6.66M | 9.69M | 9.62M | 5.28M | 3.93M | 0 | 2.41M | 2.52M | 2.12M | 1.00M |
| Deferred income tax benefit | 6.66M | 9.69M | 9.62M | 5.28M | 3.93M | 0 | 2.41M | 2.52M | 2.12M | 1.00M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 99K | -87K | 69K | 130K | -136K | 79K | -127K | 113K | 490K | -476.45K |
Inventories | -3.71M | -5.69M | -513K | -1.94M | -385K | -378K | -89K | -93K | 512K | 0 |
Accounts payable | -6.65M | 8.89M | 356K | 2.05M | -5.17M | 3.80M | -675K | 11K | -119K | 0 |
Cash generated by operating activities | -60.88M | -73.69M | -39.90M | -47.05M | -48.71M | -45.53M | -31.38M | -18.51M | -9.04M | -6.46M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -25M | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -867K | -4.34M | -1.99M | -1M | -3.67M | -5.99M | -640K | -585K | -549K | -2.07M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.12M | 20.87M | 0 |
Cash generated by investing activities | -867K | -4.34M | 23.15M | -26M | -3.67M | -5.99M | -579K | 1.5M | -526K | -2.07M |
Financing activities | ||||||||||
Common Stock Issued | 24.27M | 12K | 33.29M | 122.18M | 37.41M | 46.62M | 71.92M | 24.16M | 0 | 34.39K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -4.68M | 0 | 0 | 0 |
Repayments of term debt | 0 | 20M | -11.97M | -15.3M | 0 | 0 | 0 | -525K | 0 | 0 |
Cash used in financing activities | 22.69M | 19.44M | 44.29M | 122.39M | 37.41M | 43.61M | 67.23M | 36.48M | 21.63M | 34.39K |
Net Change In Cash | -38.94M | -59.06M | 27.86M | 49.61M | -15.05M | -8.42M | 35.41M | 19.80M | 12.08M | -8.59M |
Cash at end of period | 23.68M | 62.62M | 121.69M | 93.82M | 44.21M | 59.27M | 67.69M | 32.28M | 12.47M | 48.46M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |